S.H.N. Financial Investments Ltd. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Tenax Therapeutics, Inc. (TENX)

Filing Manager: S.H.N. Financial Investments Ltd.
Reporting Manager: S.H.N. Financial Investments Ltd.
Security: Tenax Therapeutics, Inc. Common stock, par value $0.0001
Symbol: TENX
Shares outstanding: 3.59M shares
Disclosed Ownership: 179K shares
Ownership: 4.99%
Form type: SCHEDULE 13G/A
Date filed: 3/18/2025, 04:12 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
S.H.N. Financial Investments Ltd.	4.99%	179K	179K	0	/s/ Nir Shamir	Nir Shamir, Chief Executive Officer